CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-15 | FALBERG KATHRYN E Director | Gift | −50,504 | 40,100 | ||
| 2023-06-15 | FALBERG KATHRYN E Director | Grant or award | +6,800 | 46,900 | ||
| 2023-06-15 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2023-06-07 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −4,049 | $20.04 | $81K | 59,392 |
| 2023-03-16 | Jarrett Jennifer Chief Operating Officer | Sale | −8,729 | $16.81 | $147K | 406,217 |
| 2023-01-27 | Jarrett Jennifer Chief Operating Officer | Sale | −1,600 | $23.52 | $38K | 414,946 |
| 2023-01-26 | Jarrett Jennifer Chief Operating Officer | Sale | −300 | $23.56 | $7K | 416,546 |
| 2023-01-23 | Nuyten Dimitry SA Chief Medical Officer | Grant or award | +34,000 | 76,500 | ||
| 2023-01-23 | Nuyten Dimitry SA Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +138,200 | 138,200 | ||
| 2023-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +34,000 | 63,441 | ||
| 2023-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +138,200 | 138,200 | ||
| 2023-01-23 | Tang Carolyn C. General Counsel | Grant or award | +34,000 | 97,539 | ||
| 2023-01-23 | Tang Carolyn C. General Counsel | Grant or award · Stock Option (right to buy) | +138,200 | 138,200 | ||
| 2023-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award | +45,800 | 416,846 | ||
| 2023-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +185,900 | 185,900 | ||
| 2023-01-23 | Jaen Juan C. President | Grant or award | +45,800 | 324,682 | ||
| 2023-01-23 | Jaen Juan C. President | Grant or award · Stock Option (right to buy) | +185,900 | 185,900 | ||
| 2023-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +105,700 | 469,123 | ||
| 2023-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +429,000 | 429,000 | ||
| 2022-12-16 | Goeltz II Robert C. Chief Financial Officer | Sale | −2,066 | $30.66 | $63K | 11,953 |
Page 12 of 20 · 381 trades